Glenmark Pharmaceuticals to launch Ropivacaine Hydrochloride Injection in the U.S. Market Corporates · Oct 23, 2025
Glenmark Pharmaceuticals to launch Zanubrutinib (BRUKINSA) in India after DCGI approval Corporates · Jun 9, 2025
Glenmark Pharmaceuticals to launch generic version of Adderall tablets in May 2025 Corporates · Apr 16, 2025
Glenmark Pharmaceuticals gets U.S. FDA nod for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) Corporates · Mar 20, 2025
Glenmark Pharmaceuticals acquires and launches Acetylcysteine Injection in the US Corporates · Mar 3, 2025
Glenmark Pharmaceuticals launches Epinephrine Injection USP, 10 mg/10 mL in USA Corporates · Feb 27, 2025
Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution, 0.005% in the U.S Corporates · Feb 14, 2025
Glenmark Pharmaceuticals launches Clindamycin Phosphate Foam, 1% in the US Market Corporates · Feb 12, 2025
Glenmark Pharmaceuticals shares rise over 2% on U.S. market launch of Vitamin K1 Injectable Emulsion Stock Market · Jan 21, 2025
Glenmark Pharma launches Phytonadione Injectable Emulsion USP in the U.S. market Corporates · Jan 21, 2025
Glenmark Pharmaceuticals shares in focus as company launches Travoprost Ophthalmic Solution in U.S. Stock Market · Nov 27, 2024
Glenmark Pharmaceuticals’ market cap decreases by Rs 920 crore as shares drop 2.13% today – Know More Stock Market · Nov 18, 2024